Kinetoplastid SL RNA Biogenesis
Kinetoplastid SL RNA Biogenesis
批准号:
8507127
负责人:
DAVID A CAMPBELL
金额:
$35.01万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-04-01 至 2015-06-30
关键词:
AddressAfrican TrypanosomiasisBindingBiogenesisBiologyBlood CirculationCatalytic DomainCell LineCell NucleolusCell NucleusChagas DiseaseClinicalCodeComplementComplexCore ProteinDiseaseEnzymesExonsExonucleaseFamilyFamily memberGene ExpressionGenesGeneticGenetic TranscriptionGenomeGoalsHealthHomologous GeneHumanHypermethylationIn VitroIndividualInsect VectorsInterventionKinetoplastidaKnock-outLeishmaniaLeishmaniasisLifeLinkMedicalMessenger RNAMethylationMethyltransferaseMitochondrial RNAModificationMolecularNamesNuclearNucleotidesOrganismParasitesPathway interactionsPlayPolishesPositioning AttributeProcessPropertyProtein SplicingProteinsProtozoaPseudouridineRNA ProcessingRNA SplicingReactionResearchRibonucleoproteinsRiboseRibosomal RNARoleRouteSmall Nuclear RNASmall RNASpliced Leader RNASpliced Leader SequencesStagingTechnologyTestingTherapeuticTrans-SplicingTransfer RNATranslationsTrypanosoma brucei bruceiTrypanosomatinaUridineValidationWorkchemotherapycombatfight againstgenome databasein vivoinsertion/deletion mutationinsightinterestnovelparticlepathogenprotein complexprotein purificationresearch studyrole modelspleen exonucleasetherapeutic targettraffickingvector
中文摘要
描述(由申请人提供):我们的研究旨在了解锥虫科的基因表达,该科包括负责利什曼病、非洲昏睡病和恰加斯病的寄生原生动物。重点是剪接前导(SL)RNA的起源和功能,这是一种小RNA,通过反式剪接反应将5 '端序列贡献给每个核信使RNA,并且在整个订单的一级序列水平上非常保守。反式剪接对于多顺反子前信使RNA转化为单顺反子mRNA是必需的,这可能是动质体中发现的不寻常的基因组组织的结果,并且在人类宿主或昆虫载体中没有发现,因此代表了理想的治疗靶标。该提案概述了实验,详细说明了成熟途径的SL RNA共同的利什曼原虫tarentolae和布氏锥虫在单个蛋白质和相互作用的复合物的水平,并探测SL在翻译中的作用。1)我们将探讨帽4 2 '-O-核糖甲基转移酶在T. brucei,并验证了它们在原循环T.使用敲除菌株的布氏杆菌。我们将研究TbMTr 1的帽结合特性,并测试TbMTAP和TbMTr 1在细胞核中与假尿苷合酶复合物的运输和相互作用中的作用模型。2)进一步表征参与SL RNA生物发生和功能的复合物。PTP标签、多维蛋白质鉴定技术(MudPIT)和T.布鲁氏菌基因组数据库使我们能够接近复杂的纯化。动质体特异性TbMTr 1复合蛋白TbMTAP涉及调节和结构相互作用。使用SmD 3蛋白,SL RNA RNP复合物和相关的剪接机器,催化和核心,已被捕获。在鉴定的25种蛋白质中,将验证4种新的动质体特异性蛋白质与另外两种剪接同源物的关联和功能沿着。这些目标解决了SL RNA成熟中决定其后续功能的离散步骤。反式剪接途径的特异性抑制对寄生虫是致命的,因此是临床干预的主要目标。
英文摘要
DESCRIPTION (provided by applicant): Our research is aimed at understanding gene expression in the family Trypanosomatidae, which includes the parasitic protozoa responsible for leishmaniasis, African Sleeping Sickness, and Chagas Disease. The focus is on the genesis and function of the spliced leader (SL) RNA, a small RNA that contributes the 5'-end sequence to every nuclear messenger RNA by a trans-splicing reaction and is conserved extraordinarily at the primary sequence level throughout the Order. Trans-splicing is necessary for the conversion of polycistronic pre-messenger RNA, a likely consequence of the unusual genome organization found in kinetoplastids, into monocistronic mRNA, and is not found in the human host or insect vector, thus representing an ideal therapeutic target. This proposal outlines experiments that detail the maturation pathway of the SL RNA common to Leishmania tarentolae and Trypanosoma brucei at the level of individual proteins and interacting complexes, and probe the role of the SL in translation. 1) We will explore the role of the cap 4 2'-O-ribose methyltransferases in the bloodstream form of T. brucei, and validate their function in procyclic T. brucei using knockout strains. We will investigate the cap-binding properties of TbMTr1, and test models for the role of TbMTAP and TbMTr1 in trafficking and interacting with the pseudouridine synthase complex in the nucleus. 2) To further the characterization of complexes involved in SL RNA biogenesis and function. The trinity of PTP tagging, multidimensional protein identification technology (MudPIT), and the T. brucei genome database enables us to approach complex purification. The kinetoplastid-specific TbMTr1 complex protein TbMTAP is implicated in regulatory and structural interactions. Using the SmD3 protein, the SL RNA RNP complex and associated splicing machinery, both catalytic and core, has been captured. Of the 25 proteins identified, four novel, kinetoplastid-specific proteins will be validated for association and function along with two additional splicing homologs. These goals address discrete steps in the maturation of the SL RNA that determine its subsequent function. Specific inhibition of the trans-splicing pathway is lethal to the parasite and thus a prime target for clinical intervention.
期刊论文(20)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1093/nar/gkr038
发表时间:
2011-06
期刊:
Nucleic acids research
影响因子:
14.9
作者:
[Werner M, Purta E, Kaminska KH, Cymerman IA, Campbell DA, Mittra B, Zamudio JR, Sturm NR, Jaworski J, Bujnicki JM]
通讯作者:
Bujnicki JM
DOI:
10.1093/molbev/msp083
发表时间:
2009-08
期刊:
Molecular biology and evolution
影响因子:
10.7
作者:
[Huan Zhang;D. Campbell;N. R. Sturm;Senjie Lin]
通讯作者:
Huan Zhang;D. Campbell;N. R. Sturm;Senjie Lin
DOI:
10.1093/nar/gkj084
发表时间:
2006-01-01
期刊:
NUCLEIC ACIDS RESEARCH
影响因子:
14.9
作者:
[Dunin-Horkawicz, Stanislaw, Czerwoniec, Anna, Gajda, Michal J., Feder, Marcin, Grosjean, Henri, Bujnicki, Janusz M.]
通讯作者:
Bujnicki, Janusz M.
DOI:
10.1371/journal.pgen.1004007
发表时间:
2014-02
期刊:
PLoS genetics
影响因子:
4.5
作者:
[Porcel BM, Denoeud F, Opperdoes F, Noel B, Madoui MA, Hammarton TC, Field MC, Da Silva C, Couloux A, Poulain J, Katinka M, Jabbari K, Aury JM, Campbell DA, Cintron R, Dickens NJ, Docampo R, Sturm NR, Koumandou VL, Fabre S, Flegontov P, Lukeš J, Michaeli S, Mottram JC, Szöőr B, Zilberstein D, Bringaud F, Wincker P, Dollet M]
通讯作者:
Dollet M
Trypanosoma brucei spliced leader RNA maturation by the cap 1 2'-O-ribose methyltransferase and SLA1 H/ACA snoRNA pseudouridine synthase complex.
布氏锥虫通过 cap 1 2-O-核糖甲基转移酶和 SLA1 H/ACA snoRNA 假尿苷合酶复合物剪接前导 RNA 成熟。
DOI:
10.1128/mcb.01496-08
发表时间:
2009
期刊:
Molecular and cellular biology
影响因子:
5.3
作者:
[Zamudio,JesseR, Mittra,Bidyottam, Chattopadhyay,Arnab, Wohlschlegel,JamesA, Sturm,NancyR, Campbell,DavidA]
通讯作者:
Campbell,DavidA
共 11 条
Cap binding and gene expression in trypanosomes
-
批准号:8538532
-
项目类别:
-
资助金额:$5.26万
-
财政年份:2012
-
负责人:DAVID A CAMPBELL
-
依托单位:
Cap binding and gene expression in trypanosomes
-
批准号:8720092
-
项目类别:
-
资助金额:$5.37万
-
财政年份:2012
-
负责人:DAVID A CAMPBELL
-
依托单位:
Cap binding and gene expression in trypanosomes
-
批准号:8152809
-
项目类别:
-
资助金额:$6.89万
-
财政年份:2012
-
负责人:DAVID A CAMPBELL
-
依托单位:
Global sumoylation analysis in Trypanosoma brucei
-
批准号:7825383
-
项目类别:
-
资助金额:$19.25万
-
财政年份:2009
-
负责人:DAVID A CAMPBELL
-
依托单位:
Global sumoylation analysis in Trypanosoma brucei
-
批准号:7659346
-
项目类别:
-
资助金额:$23.1万
-
财政年份:2009
-
负责人:DAVID A CAMPBELL
-
依托单位:
Translational partitioning of the SL RNA
-
批准号:7847643
-
项目类别:
-
资助金额:$19.25万
-
财政年份:2009
-
负责人:DAVID A CAMPBELL
-
依托单位:
Translational partitioning of the SL RNA
-
批准号:7472824
-
项目类别:
-
资助金额:$23.1万
-
财政年份:2009
-
负责人:DAVID A CAMPBELL
-
依托单位:
Kinetoplastid SL RNA biogenesis
-
批准号:7196546
-
项目类别:
-
资助金额:$35.34万
-
财政年份:2004
-
负责人:DAVID A CAMPBELL
-
依托单位:
Kinetoplastid SL RNA biogenesis
-
批准号:6873642
-
项目类别:
-
资助金额:$37.32万
-
财政年份:2004
-
负责人:DAVID A CAMPBELL
-
依托单位:
Kinetoplastid SL RNA Biogenesis
-
批准号:8284373
-
项目类别:
-
资助金额:$37.24万
-
财政年份:2004
-
负责人:DAVID A CAMPBELL
-
依托单位:
Kinetoplastid SL RNA biogenesis
-
批准号:7024522
-
项目类别:
-
资助金额:$36.39万
-
财政年份:2004
-
负责人:DAVID A CAMPBELL
-
依托单位:
Kinetoplastid SL RNA biogenesis
-
批准号:6777287
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2004
-
负责人:DAVID A CAMPBELL
-
依托单位:
Kinetoplastid SL RNA biogenesis
-
批准号:7386049
-
项目类别:
-
资助金额:$34.67万
-
财政年份:2004
-
负责人:DAVID A CAMPBELL
-
依托单位:
Kinetoplastid SL RNA Biogenesis
-
批准号:7877047
-
项目类别:
-
资助金额:$37.62万
-
财政年份:2004
-
负责人:DAVID A CAMPBELL
-
依托单位:
Kinetoplastid SL RNA Biogenesis
-
批准号:7749899
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2004
-
负责人:DAVID A CAMPBELL
-
依托单位:
Kinetoplastid SL RNA Biogenesis
-
批准号:8091461
-
项目类别:
-
资助金额:$37.24万
-
财政年份:2004
-
负责人:DAVID A CAMPBELL
-
依托单位:
EXPRESSION OF THE LEISHMANIA TARENTOLAE SL RNA GENE
-
批准号:6510655
-
项目类别:
-
资助金额:$25.49万
-
财政年份:1994
-
负责人:DAVID A CAMPBELL
-
依托单位:
EXPRESSION OF THE LEISHMANIA TARENTOLAE SL RNA GENE
-
批准号:6631930
-
项目类别:
-
资助金额:$26.26万
-
财政年份:1994
-
负责人:DAVID A CAMPBELL
-
依托单位:
EXPRESSION OF THE LEISHMANIA TARENTOLAE SL RNA GENE
-
批准号:6362312
-
项目类别:
-
资助金额:$24.75万
-
财政年份:1994
-
负责人:DAVID A CAMPBELL
-
依托单位:
EXPRESSION OF THE LEISHMANIA TARENTOLAE MINI EXON GENE
-
批准号:2069671
-
项目类别:
-
资助金额:$20.34万
-
财政年份:1994
-
负责人:DAVID A CAMPBELL
-
依托单位:
海外基金